C

CytoReason

133 employees

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Atopic Dermatitis
Combinations
Artificial Intelligence
Indications
Pharmaceutical
Computational Drug Discovery
Machine Learning
Cells
Data Science
Health Diagnostics
Health Care
Cancer Immunotherapy
Immune System
Biomarker Discovery
Target Discovery
Patient Stratification
Inflammatory Bowel Disease
Biopharma
Bioinformatics
Indication Prioritisation

Date founded

2016

Funding rounds raised

C

CytoReason raised undisclosed on January 4, 2022

Investors: Asymmetry Ventures

C

CytoReason raised undisclosed on June 9, 2021

Investors: OurCrowd

FAQ